Pedinol Pharmacal Inc

pedinol.com

For over 80 years, PEDiNOL has been a privately held, specialty pharmaceutical company focused on meeting the needs of podiatrists and their patients. Our mission is to serve podiatrists by delivering high quality products supported by attentive customer service.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

XTALPI ANNOUNCES COLLABORATION WITH LILLY, USING AI + ROBOTICS TO UNCOVER FIRST-IN-CLASS THERAPEUTICS

PRNewswire | May 31, 2023

news image

Today, XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Company. The collaboration will leverage XtalPi's integrated AI capabilities and robotics platform to de novo design and deliver drug candidates for an undisclosed target. XtalPi has established itself as an industry leader in combining...

Read More

PHARMACY MARKET

HALOZYME ANNOUNCES POSITIVE CLINICAL DATA OF ITS HIGH-VOLUME AUTO-INJECTOR DEMONSTRATING SUCCESSFUL RAPID SUBCUTANEOUS DRUG DELIVERY

PR Newswire | October 19, 2023

news image

Halozyme Therapeutics, Inc. announced positive results of a clinical study demonstrating subcutaneous administration of 10 mL of a representative biologic product co-formulated with its ENHANZE® drug delivery technology, in approximately 30 seconds. In the study, the biologic was delivered with Halozyme's proprietary high-volume auto-injector (HVAI) in healthy volunteers. The injecti...

Read More

Business Insights

PCI PHARMA SERVICES SELECTS THOUGHTWORKS FOR DIGITAL PLATFORM TRANSFORMATION WITH AGILE APPROACH

Thoughtworks | July 11, 2022

news image

Thoughtworks a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, today announced the signing of a multi-year agreement with PCI Pharma Services, a leading global contract development and manufacturing organization. Thoughtworks will help PCI in its journey to digitize its supply chain, with the goal of accelerating the time it takes to bring clients’ life-changing therapies to market for patients. By co-developing too...

Read More

Business Insights, PHARMACY MARKET

VERO BIOTECH ANNOUNCES FDA APPROVAL FOR ITS SECOND-GEN GENOSYL DS

VERO Biotech | February 03, 2023

news image

On February 2, 2023, VERO Biotech Inc., a commercial-stage biotechnology company focused on neonatal intensive care and the acute care hospital community, announced that FDA has approved its innovative second-generation GENOSYL® Inhaled Nitric Oxide (iNO) delivery system for use in the operating room with rebreathing anesthesia. The second generation GENOSYL® DS is now the first and only iNO delivery device approved for use in both rebreathing and non-rebreathing anesthesia procedu...

Read More
news image

Pharma Tech

XTALPI ANNOUNCES COLLABORATION WITH LILLY, USING AI + ROBOTICS TO UNCOVER FIRST-IN-CLASS THERAPEUTICS

PRNewswire | May 31, 2023

Today, XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Company. The collaboration will leverage XtalPi's integrated AI capabilities and robotics platform to de novo design and deliver drug candidates for an undisclosed target. XtalPi has established itself as an industry leader in combining...

Read More
news image

PHARMACY MARKET

HALOZYME ANNOUNCES POSITIVE CLINICAL DATA OF ITS HIGH-VOLUME AUTO-INJECTOR DEMONSTRATING SUCCESSFUL RAPID SUBCUTANEOUS DRUG DELIVERY

PR Newswire | October 19, 2023

Halozyme Therapeutics, Inc. announced positive results of a clinical study demonstrating subcutaneous administration of 10 mL of a representative biologic product co-formulated with its ENHANZE® drug delivery technology, in approximately 30 seconds. In the study, the biologic was delivered with Halozyme's proprietary high-volume auto-injector (HVAI) in healthy volunteers. The injecti...

Read More
news image

Business Insights

PCI PHARMA SERVICES SELECTS THOUGHTWORKS FOR DIGITAL PLATFORM TRANSFORMATION WITH AGILE APPROACH

Thoughtworks | July 11, 2022

Thoughtworks a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, today announced the signing of a multi-year agreement with PCI Pharma Services, a leading global contract development and manufacturing organization. Thoughtworks will help PCI in its journey to digitize its supply chain, with the goal of accelerating the time it takes to bring clients’ life-changing therapies to market for patients. By co-developing too...

Read More
news image

Business Insights, PHARMACY MARKET

VERO BIOTECH ANNOUNCES FDA APPROVAL FOR ITS SECOND-GEN GENOSYL DS

VERO Biotech | February 03, 2023

On February 2, 2023, VERO Biotech Inc., a commercial-stage biotechnology company focused on neonatal intensive care and the acute care hospital community, announced that FDA has approved its innovative second-generation GENOSYL® Inhaled Nitric Oxide (iNO) delivery system for use in the operating room with rebreathing anesthesia. The second generation GENOSYL® DS is now the first and only iNO delivery device approved for use in both rebreathing and non-rebreathing anesthesia procedu...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us